SG186876A1 - New pcr sequencing method and use thereof in hla genotyping - Google Patents
New pcr sequencing method and use thereof in hla genotyping Download PDFInfo
- Publication number
- SG186876A1 SG186876A1 SG2012096616A SG2012096616A SG186876A1 SG 186876 A1 SG186876 A1 SG 186876A1 SG 2012096616 A SG2012096616 A SG 2012096616A SG 2012096616 A SG2012096616 A SG 2012096616A SG 186876 A1 SG186876 A1 SG 186876A1
- Authority
- SG
- Singapore
- Prior art keywords
- hla
- pcr
- seq
- sequencing
- pcr primers
- Prior art date
Links
- 238000012163 sequencing technique Methods 0.000 title claims abstract description 307
- 238000003205 genotyping method Methods 0.000 title claims abstract description 87
- 238000000034 method Methods 0.000 claims abstract description 208
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims abstract description 98
- 108010075704 HLA-A Antigens Proteins 0.000 claims abstract description 84
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims abstract description 64
- 108010052199 HLA-C Antigens Proteins 0.000 claims abstract description 64
- 102100036241 HLA class II histocompatibility antigen, DQ beta 1 chain Human genes 0.000 claims abstract description 27
- 238000004458 analytical method Methods 0.000 claims abstract description 15
- 108010067148 HLA-DQbeta antigen Proteins 0.000 claims abstract description 3
- 108020004414 DNA Proteins 0.000 claims description 212
- 108700024394 Exon Proteins 0.000 claims description 135
- 230000003321 amplification Effects 0.000 claims description 127
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 127
- 239000000203 mixture Substances 0.000 claims description 77
- 238000010008 shearing Methods 0.000 claims description 76
- 238000000746 purification Methods 0.000 claims description 66
- 108090000623 proteins and genes Proteins 0.000 claims description 30
- 210000004369 blood Anatomy 0.000 claims description 28
- 239000008280 blood Substances 0.000 claims description 28
- 239000012634 fragment Substances 0.000 claims description 27
- 238000012408 PCR amplification Methods 0.000 claims description 26
- 108010065026 HLA-DQB1 antigen Proteins 0.000 claims description 24
- 238000010276 construction Methods 0.000 claims description 22
- 238000011084 recovery Methods 0.000 claims description 21
- 108020004707 nucleic acids Proteins 0.000 claims description 19
- 102000039446 nucleic acids Human genes 0.000 claims description 19
- 150000007523 nucleic acids Chemical class 0.000 claims description 19
- 238000001712 DNA sequencing Methods 0.000 claims description 18
- 238000001962 electrophoresis Methods 0.000 claims description 17
- 101150118346 HLA-A gene Proteins 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 238000007480 sanger sequencing Methods 0.000 claims description 16
- 101150076489 B gene Proteins 0.000 claims description 15
- 108010039343 HLA-DRB1 Chains Proteins 0.000 claims description 15
- 102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 claims description 14
- 238000011176 pooling Methods 0.000 claims description 14
- 101150035071 HLA-C gene Proteins 0.000 claims description 12
- 239000011324 bead Substances 0.000 claims description 10
- 238000002864 sequence alignment Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 102000012410 DNA Ligases Human genes 0.000 claims description 5
- 108010061982 DNA Ligases Proteins 0.000 claims description 5
- 230000004544 DNA amplification Effects 0.000 claims description 5
- 230000006862 enzymatic digestion Effects 0.000 claims description 5
- -1 preferably Proteins 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 101150046128 HLA-DQB1 gene Proteins 0.000 claims description 2
- 108091033319 polynucleotide Proteins 0.000 claims 4
- 102000040430 polynucleotide Human genes 0.000 claims 4
- 239000002157 polynucleotide Substances 0.000 claims 4
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 154
- 101100284398 Bos taurus BoLA-DQB gene Proteins 0.000 description 75
- 238000006243 chemical reaction Methods 0.000 description 58
- 101001100327 Homo sapiens RNA-binding protein 45 Proteins 0.000 description 41
- 102100038823 RNA-binding protein 45 Human genes 0.000 description 41
- 102210048101 A*01:01 Human genes 0.000 description 34
- 239000000499 gel Substances 0.000 description 31
- 102210047220 C*07:02 Human genes 0.000 description 30
- 239000013642 negative control Substances 0.000 description 25
- 102210042962 C*03:04 Human genes 0.000 description 24
- 238000003753 real-time PCR Methods 0.000 description 22
- 108091028043 Nucleic acid sequence Proteins 0.000 description 19
- 238000000605 extraction Methods 0.000 description 18
- 108091035707 Consensus sequence Proteins 0.000 description 16
- 239000003550 marker Substances 0.000 description 15
- 238000000246 agarose gel electrophoresis Methods 0.000 description 12
- 239000007795 chemical reaction product Substances 0.000 description 11
- 241001504639 Alcedo atthis Species 0.000 description 9
- 102210047469 A*02:01 Human genes 0.000 description 8
- 239000000427 antigen Substances 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 230000002457 bidirectional effect Effects 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 102000054766 genetic haplotypes Human genes 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 102210047473 B*57:01 Human genes 0.000 description 6
- 102210047482 DRB1*07:01 Human genes 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000012149 elution buffer Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 108700028369 Alleles Proteins 0.000 description 5
- 102210047362 DRB1*15:01 Human genes 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102210048100 A*31:01 Human genes 0.000 description 4
- 108091093088 Amplicon Proteins 0.000 description 4
- 102210047595 B*52:01 Human genes 0.000 description 4
- 102210043140 C*04:01 Human genes 0.000 description 4
- 102210047597 C*06:02 Human genes 0.000 description 4
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 4
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 102210047598 C*12:02 Human genes 0.000 description 3
- 102000004594 DNA Polymerase I Human genes 0.000 description 3
- 108010017826 DNA Polymerase I Proteins 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 3
- 239000003147 molecular marker Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 238000010408 sweeping Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 102210047117 A*02:05 Human genes 0.000 description 2
- 102210042961 A*03:01 Human genes 0.000 description 2
- 102100022715 Acetyl-coenzyme A thioesterase Human genes 0.000 description 2
- 102210047218 B*07:02 Human genes 0.000 description 2
- 102210048102 B*08:01 Human genes 0.000 description 2
- 101150111062 C gene Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102210042965 DQB1*06:02 Human genes 0.000 description 2
- 102210048119 DRB1*12:01 Human genes 0.000 description 2
- 102210047784 DRB1*13:02 Human genes 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 101000678862 Homo sapiens Acetyl-coenzyme A thioesterase Proteins 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000007481 next generation sequencing Methods 0.000 description 2
- 238000012175 pyrosequencing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 101150084750 1 gene Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102210047212 DQB1*02:02 Human genes 0.000 description 1
- 102210047287 DQB1*03:02 Human genes 0.000 description 1
- 102210048109 DRB1*01:01 Human genes 0.000 description 1
- 102210047356 DRB1*03:01 Human genes 0.000 description 1
- 102210048113 DRB1*04:03 Human genes 0.000 description 1
- 102210042966 DRB1*04:04 Human genes 0.000 description 1
- 102210047483 DRB1*11:01 Human genes 0.000 description 1
- 102210012675 DRB1*15 Human genes 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 description 1
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
- 108010058607 HLA-B Antigens Proteins 0.000 description 1
- 101150000578 HLA-B gene Proteins 0.000 description 1
- 101100395318 Homo sapiens HLA-G gene Proteins 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 102000043129 MHC class I family Human genes 0.000 description 1
- 108091054437 MHC class I family Proteins 0.000 description 1
- 241000282561 Macaca nemestrina Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000002998 immunogenetic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000012177 large-scale sequencing Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000011451 sequencing strategy Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010213721 CN101921842B (zh) | 2010-06-30 | 2010-06-30 | Hla-a,b基因分型用pcr引物及其使用方法 |
| CN201010213717.6A CN101921840B (zh) | 2010-06-30 | 2010-06-30 | 一种基于dna分子标签技术和dna不完全打断策略的pcr测序方法 |
| CN201010213719.5A CN101921841B (zh) | 2010-06-30 | 2010-06-30 | 基于Illumina GA测序技术的HLA基因高分辨率分型方法 |
| PCT/CN2010/002149 WO2012083505A1 (zh) | 2010-12-24 | 2010-12-24 | Hla-c基因分型的方法及其相关引物 |
| PCT/CN2010/002150 WO2012083506A1 (zh) | 2010-12-24 | 2010-12-24 | Hla-dqb1基因分型的方法及其相关引物 |
| PCT/CN2011/076688 WO2012000445A1 (zh) | 2010-06-30 | 2011-06-30 | 新的的pcr测序方法及其在hla基因分型中的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG186876A1 true SG186876A1 (en) | 2013-02-28 |
Family
ID=45401405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012096616A SG186876A1 (en) | 2010-06-30 | 2011-06-30 | New pcr sequencing method and use thereof in hla genotyping |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9957564B2 (enExample) |
| EP (1) | EP2599877B1 (enExample) |
| JP (1) | JP5968879B2 (enExample) |
| KR (1) | KR101709826B1 (enExample) |
| AU (1) | AU2011274090B2 (enExample) |
| BR (1) | BR112012032586B1 (enExample) |
| CA (1) | CA2803940C (enExample) |
| DK (1) | DK2599877T3 (enExample) |
| MY (1) | MY173793A (enExample) |
| RU (1) | RU2587606C2 (enExample) |
| SG (1) | SG186876A1 (enExample) |
| WO (1) | WO2012000445A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201708498VA (en) * | 2013-04-17 | 2017-11-29 | Agency Science Tech & Res | Method for generating extended sequence reads |
| JP6308724B2 (ja) | 2013-05-09 | 2018-04-11 | ジェノダイブファーマ株式会社 | Ｈｌａ遺伝子のマルチプレックスｄｎａタイピング方法及びキット |
| WO2015031385A1 (en) * | 2013-08-26 | 2015-03-05 | The Translational Genomics Research Institute | Single molecule-overlapping read analysis for minor variant mutation detection in pathogen samples |
| GB201409282D0 (en) | 2014-05-23 | 2014-07-09 | Univ Sydney Tech | Sequencing process |
| JP2017525369A (ja) * | 2014-09-05 | 2017-09-07 | キアゲン ゲーエムベーハー | アダプター連結アンプリコンの調製 |
| CN105400864B (zh) * | 2014-09-12 | 2020-04-14 | 深圳华大基因股份有限公司 | 用于基于血液样品构建测序文库的方法及其在确定胎儿遗传异常中的用途 |
| EP3192869B1 (en) * | 2014-09-12 | 2019-03-27 | MGI Tech Co., Ltd. | Isolated oligonucleotide and use thereof in nucleic acid sequencing |
| US10233490B2 (en) | 2014-11-21 | 2019-03-19 | Metabiotech Corporation | Methods for assembling and reading nucleic acid sequences from mixed populations |
| US9859394B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
| US9618474B2 (en) | 2014-12-18 | 2017-04-11 | Edico Genome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
| EP3235010A4 (en) | 2014-12-18 | 2018-08-29 | Agilome, Inc. | Chemically-sensitive field effect transistor |
| US10006910B2 (en) | 2014-12-18 | 2018-06-26 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same |
| US10020300B2 (en) | 2014-12-18 | 2018-07-10 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
| US9857328B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same |
| CN107002153B (zh) * | 2015-02-04 | 2020-10-27 | 深圳华大生命科学研究院 | 一种构建长片段测序文库的方法 |
| KR101651817B1 (ko) * | 2015-10-28 | 2016-08-29 | 대한민국 | Ngs 라이브러리 제작용 프라이머 세트 및 이를 이용한 ngs 라이브러리 제작방법 및 키트 |
| CN108699600A (zh) * | 2016-02-23 | 2018-10-23 | 诺维信公司 | 改进的新一代测序 |
| WO2017201081A1 (en) | 2016-05-16 | 2017-11-23 | Agilome, Inc. | Graphene fet devices, systems, and methods of using the same for sequencing nucleic acids |
| ES2870639T3 (es) | 2016-10-24 | 2021-10-27 | Geneinfosec Inc | Ocultación de información presente en los ácidos nucleicos |
| CN110167951A (zh) * | 2016-11-15 | 2019-08-23 | 奎斯特诊断投资有限责任公司 | 使用mitra尖端提取检测dna突变的方法 |
| JP2020501601A (ja) * | 2016-11-15 | 2020-01-23 | クエスト ダイアグノスティックス インヴェストメンツ エルエルシー | Ｍｉｔｒａチップ抽出を使用して嚢胞性線維症の変異を検出するための方法 |
| EP3626835A1 (en) | 2018-09-18 | 2020-03-25 | Sistemas Genómicos, S.L. | Method for genotypically identifying both alleles of at least one locus of a subject's hla gene |
| RU2703401C1 (ru) * | 2018-10-24 | 2019-10-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Тест-система для выявления и генотипирования РНК вируса репродуктивно-респираторного синдрома свиней |
| RU2703394C1 (ru) * | 2018-10-24 | 2019-10-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Способ выявления и генотипирования РНК вируса репродуктивно-респираторного синдрома свиней |
| FR3100820B1 (fr) | 2019-09-12 | 2024-06-28 | Bionobis | Procédé de génotypage adapté au traitement d’un grand nombre d’échantillons, notamment en cas de polymorphisme élevé |
| FR3106596B1 (fr) | 2020-01-27 | 2022-12-02 | Bionobis | Procede de genotypage hla simple et rapide |
| CN111235266B (zh) * | 2020-03-10 | 2023-12-01 | 广州医科大学附属第二医院 | Hla亚型检测试剂盒及其应用 |
| FR3110178B1 (fr) | 2020-05-18 | 2022-05-27 | Bionobis | Procédé de génotypage adapté au traitement simultané d’un grand nombre de patients |
| CN112553313A (zh) * | 2020-12-30 | 2021-03-26 | 武汉康圣达医学检验所有限公司 | 用于Sanger法的测序反应产物的变性方法 |
| KR102507110B1 (ko) * | 2022-02-15 | 2023-03-07 | 주식회사 네오젠티씨 | 주조직 적합성 복합체의 타입들을 분석하기 위한 방법 및 장치 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0656065A1 (en) * | 1991-10-31 | 1995-06-07 | University Of Pittsburgh | Reverse dot blot hybridization using tandem head-to-tail monomers containing probes synthesized by staggered complementary primers |
| US5580730A (en) * | 1994-08-19 | 1996-12-03 | Olympus America, Inc. | Enzyme digestion method for the detection of amplified DNA |
| AU6321998A (en) | 1997-02-11 | 1998-08-26 | William H. Hildebrand | Class i sequence based typing of hla-a, -b, and -c alleles by direct dna sequencing |
| EP0953650A1 (en) * | 1998-04-20 | 1999-11-03 | Innogenetics N.V. | Method for typing of HLA alleles |
| CA2513535C (en) * | 2003-01-29 | 2012-06-12 | 454 Corporation | Bead emulsion nucleic acid amplification |
| US7300755B1 (en) * | 2003-05-12 | 2007-11-27 | Fred Hutchinson Cancer Research Center | Methods for haplotyping genomic DNA |
| WO2005042764A2 (en) | 2003-10-28 | 2005-05-12 | Dynal Biotech Llc | Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles |
| US9365893B2 (en) * | 2005-05-10 | 2016-06-14 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Methods of mapping polymorphisms and polymorphism microarrays |
| EP2477029A1 (en) * | 2005-06-02 | 2012-07-18 | Fluidigm Corporation | Analysis using microfluidic partitioning devices |
| AU2006295556B2 (en) | 2005-09-29 | 2012-07-05 | Keygene N.V. | High throughput screening of mutagenized populations |
| US8071310B2 (en) | 2005-11-14 | 2011-12-06 | Keygene Nv | Method for the high throughput screening of transposon tagging populations and massive parallel sequence identification of insertion sites |
| DK3404114T3 (da) * | 2005-12-22 | 2021-06-28 | Keygene Nv | Fremgangsmåde til detektering af AFLP-baseret polymorfisme med højt gennemløb |
| US20110002948A1 (en) | 2006-06-09 | 2011-01-06 | Conexio 4 Pty Ltd | Identification of a nucleic acid molecule |
| US20100086914A1 (en) * | 2008-10-03 | 2010-04-08 | Roche Molecular Systems, Inc. | High resolution, high throughput hla genotyping by clonal sequencing |
| JP2011500041A (ja) * | 2007-10-16 | 2011-01-06 | エフ．ホフマン−ラ ロシュ アーゲー | クローナルシークエンシングによる高分解能かつ高効率のｈｌａ遺伝子型決定法 |
| RU2393231C1 (ru) * | 2008-12-29 | 2010-06-27 | Федеральное государственное учреждение здравоохранения "Российский научно-исследовательский противочумный институт "Микроб" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека ("РосНИПЧИ "Микроб") | Способ определения генетического родства штаммов холерных вибрионов методом секвенирования генов, фланкирующих кластер генов биосинтеза о-антигена |
| CN101921840B (zh) | 2010-06-30 | 2014-06-25 | 深圳华大基因科技有限公司 | 一种基于dna分子标签技术和dna不完全打断策略的pcr测序方法 |
| CN101921841B (zh) | 2010-06-30 | 2014-03-12 | 深圳华大基因科技有限公司 | 基于Illumina GA测序技术的HLA基因高分辨率分型方法 |
| CN101921842B (zh) | 2010-06-30 | 2013-08-07 | 深圳华大基因科技有限公司 | Hla-a,b基因分型用pcr引物及其使用方法 |
-
2011
- 2011-06-30 EP EP11800190.8A patent/EP2599877B1/en active Active
- 2011-06-30 MY MYPI2012005591A patent/MY173793A/en unknown
- 2011-06-30 RU RU2013103795/10A patent/RU2587606C2/ru active IP Right Revival
- 2011-06-30 AU AU2011274090A patent/AU2011274090B2/en active Active
- 2011-06-30 SG SG2012096616A patent/SG186876A1/en unknown
- 2011-06-30 CA CA2803940A patent/CA2803940C/en active Active
- 2011-06-30 JP JP2013516983A patent/JP5968879B2/ja active Active
- 2011-06-30 BR BR112012032586-8A patent/BR112012032586B1/pt active IP Right Grant
- 2011-06-30 WO PCT/CN2011/076688 patent/WO2012000445A1/zh not_active Ceased
- 2011-06-30 US US13/807,660 patent/US9957564B2/en active Active
- 2011-06-30 DK DK11800190.8T patent/DK2599877T3/da active
- 2011-06-30 KR KR1020137002332A patent/KR101709826B1/ko active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2599877B1 (en) | 2017-09-27 |
| WO2012000445A1 (zh) | 2012-01-05 |
| DK2599877T3 (da) | 2017-11-20 |
| JP2013529472A (ja) | 2013-07-22 |
| CA2803940C (en) | 2019-07-02 |
| AU2011274090B2 (en) | 2015-04-09 |
| EP2599877A1 (en) | 2013-06-05 |
| AU2011274090A1 (en) | 2013-02-07 |
| BR112012032586B1 (pt) | 2021-08-17 |
| RU2013103795A (ru) | 2014-08-20 |
| JP5968879B2 (ja) | 2016-08-10 |
| RU2587606C2 (ru) | 2016-06-20 |
| MY173793A (en) | 2020-02-24 |
| BR112012032586A2 (pt) | 2019-07-30 |
| EP2599877A4 (en) | 2014-01-01 |
| CA2803940A1 (en) | 2012-01-05 |
| KR101709826B1 (ko) | 2017-02-24 |
| US20130237432A1 (en) | 2013-09-12 |
| US9957564B2 (en) | 2018-05-01 |
| KR20130038353A (ko) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2803940C (en) | Application of a pcr sequencing method, based on dna barcoding technique and dna incomplete shearing strategy, in hla genotyping | |
| AU2007313472B2 (en) | Population scale HLA-typing and uses thereof | |
| CN108460246A (zh) | 一种基于三代测序平台的hla基因分型方法 | |
| WO2012000150A1 (zh) | Hla-a，b基因分型用pcr引物及其使用方法 | |
| CN106755329A (zh) | 基于二代测序技术检测α和β地中海贫血点突变的方法及试剂盒 | |
| WO2011030159A1 (en) | Method using hla epitope determination | |
| Dunn | Novel approaches and technologies in molecular HLA typing | |
| CN103270170B (zh) | Hla-dqb1基因分型的方法及其相关引物 | |
| TWI542696B (zh) | HLA - C genotyping and its related primers | |
| JP2009261358A (ja) | Ｈｌａ−ｄｒｂ１遺伝子を含むヒト遺伝子のアレル多型のタイピング方法及びこれに用いるキット | |
| WO2017135396A1 (ja) | Ｐｃｒを用いないキャプチャー法によるｈｌａ遺伝子タイピング用プローブセット及びそれを用いたタイピング方法 | |
| EP1951894A1 (en) | Microarrays for genotyping and methods of use | |
| CN114540486A (zh) | 一种hla-dpa1基因全长扩增引物组、分型试剂盒 | |
| RU2837865C1 (ru) | Способ секвенирования экзонов гена HLA-DPA1 и набор синтетических олигонуклеотидов для его реализации | |
| Tambe et al. | Characterization of the novel HLA‐B* 58: 01: 01: 19 allele by next‐generation sequencing. | |
| De Santis et al. | KIR Genotyping | |
| JP2010162020A (ja) | 新規ｈｌａ−ｄｒｂ１遺伝子およびその用途 | |
| AU2013273684A1 (en) | Population scale hla-typing and uses thereof | |
| HK1185115B (en) | Method for hla-dqb1 genotyping and related primers thereof | |
| HK1185114B (en) | Method for hla-c genotyping and related primers thereof | |
| JP2011050377A (ja) | 新規ｈｌａ−ｄｒｂ１遺伝子およびその用途 |